ATOS
USDAtossa Therapeutics Inc. Common Stock
$0.878-0.008 (-0.903%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.886
High
$0.934
Low
$0.870
Volume
0.52M
Company Fundamentals
Market Cap
113.4M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.69M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.55Current $0.878High $1.66
Related News
Analyst Upgrades
Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.5
Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics with a Buy and raises the price target from $7.25 to $7.5.
View more
Analyst Upgrades
Craig-Hallum Initiates Coverage On Atossa Therapeutics with Buy Rating, Announces Price Target of $4
Craig-Hallum analyst Albert Lowe initiates coverage on Atossa Therapeutics with a Buy rating and announces Price Target of $4.
View more
PR Newswire
Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference
Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.